Child/adolescent anxiety multimodal study: Evaluating safety

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 54, Issue 3, 2015, Pages 180-190

  Rynn, Moira A ^a   Walkup, John T ^b   Compton, Scott N ^c   Sakolsky, Dara J ^d   Sherrill, Joel T ^e   Shen, Sa ^f   Kendall, Philip C ^g   McCracken, James ^h   Albano, Anne Marie ^a   Piacentini, John ^h   Riddle, Mark A ⁱ   Keeton, Courtney ⁱ   Waslick, Bruce ^j   Chrisman, Allan ^c   Iyengar, Satish ^d   March, John S ^c   Birmaher, Boris ^d  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^f UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^g TEMPLE UNIVERSITY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j BAYSTATE MEDICAL CENTER   (United States)

more..

Author keywords

adverse events; anxiety; selective serotonin reuptake inhibitors

Indexed keywords

PLACEBO; SERTRALINE; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; AGE; AGITATION; ANXIETY DISORDER; ARTICLE; ASTHMA; CHILD; CHILD PSYCHIATRY; CLINICAL GLOBAL IMPRESSION SCALE; COGNITIVE THERAPY; COMMON COLD SYMPTOM; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SAFETY; DSM-IV; DYSPNEA; FATIGUE; FEMALE; FUNCTIONAL DISEASE; GASTROINTESTINAL SYMPTOM; GENERALIZED ANXIETY DISORDER; HUMAN; IMPULSIVENESS; INSOMNIA; IRRITABILITY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALAISE; MALE; MEDICATION COMPLIANCE; MOTOR ACTIVITY; NAUSEA; OTALGIA; PARESTHESIA; PATIENT COMPLIANCE; PHYSICAL SYMPTOM CHECKLIST; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SCORING SYSTEM; SEDATION; SEPARATION ANXIETY; SKIN TINGLING; SLEEP DISORDER; SOCIAL PHOBIA; SORE THROAT; STOMACH PAIN; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; VOMITING; ANXIETY, SEPARATION; CLINICAL TRIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PHASE 3 CLINICAL TRIAL; PHOBIC DISORDERS; PSYCHOLOGICAL RATING SCALE; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

ADOLESCENT; ANXIETY, SEPARATION; CHILD; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PHOBIC DISORDERS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84923625835     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1016/j.jaac.2014.12.015     Document Type: Article

References (34)

1. K. Beesdo, S. Knappe, and D.S. Pine Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V Psychiatr Clin N Am 32 2009 483 524
2. E.J. Costello, H.L. Egger, and A. Angold The developmental epidemiology of anxiety disorders: phenomenology, prevalence, and comorbidity Child Adolesc Psychiatr Clin N Am 14 2005 631 648
3. C.S. Dweck, and C.B. Wortman Learned Helplessness, Anxiety, and Achievement Motivation: Neglected Parallels in Cognitive, Affective, and Coping Responses. Series in Clinical and Community Psychology: Achievement, Stress, and Anxiety 1982 Hemisphere Washington, DC 93 125
4. C.C. Strauss, C.A. Lease, A.E. Kazdin, M.K. Dulcan, and C.G. Last Multimethod assessment of the social competence of children with anxiety disorders J Clin Child Psychol 18 1989 184 189
5. P.C. Kendall, S. Safford, E. Flannery-Schroeder, and A. Webb Child anxiety treatment: outcomes in adolescence and impact on substance use and depression at 7.4-year follow-up J Consult Clin Psychol 72 2004 276 287
6. D.S. Pine, P. Cohen, D. Gurley, J. Brook, and Y. Ma The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders Arch Gen Psychiatry 55 1998 56 64
7. S.N. Compton, J.S. March, D. Brent, A.M. Albano, V.R. Weersing, and J. Curry Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review J Am Acad Child Adolesc Psychiatry 43 2004 930 959
8. P.C. Kendall, C.A. Settipani, and C.M. Cummings No need to worry: the promising future of child anxiety research J Clin Child Adolesc Psychol 41 2012 103 115
9. H.B. Vidair, C.N. Fichter, K.L. Kunkle, and A.S. Boccia Targeting parental psychopathology in child anxiety Child Adolesc Psychiatr Clin N Am 21 2012 669 689
10. J.C. Ipser, D.J. Stein, S. Hawkridge, and L. Hoppe Pharmacotherapy for anxiety disorders in children and adolescents Cochrane Database Syst Rev 2009 CD005170
11. D.S. Pine, J.T. Walkup, and M.J. Labellarte Fluvoxamine for the treatment of anxiety disorders in children and adolescents N Engl J Med 344 2001 1279 1285
12. M. Rynn, A. Puliafico, C. Heleniak, P. Rikhi, K. Ghalib, and H. Vidair Advances in pharmacotherapy for pediatric anxiety disorders Depress Anxiety 28 2011 76 87
13. J.F. Velosa, and M.A. Riddle Pharmacologic treatment of anxiety disorders in children and adolescents Child Adolesc Psychiatr Clin N Am 9 2000 119 133
14. Strawn JR, Prakash A, Zhang Q, et al. A randomized, placebo-controlled study of duloxetine for the treatment of children (7-11 years) and adolescents (12-17 years) with generalized anxiety disorder. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, October 22-27, 2013, Orlando, FL.
15. B. Birmaher, D.A. Axelson, and K. Monk Fluoxetine for the treatment of childhood anxiety disorders J Am Acad Child Adolesc Psychiatry 42 2003 415 423
16. J.S. March, J. Biederman, and R. Wolkow Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial JAMA 280 1998 1752 1756
17. K.D. Wagner, P. Ambrosini, and M. Rynn Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials JAMA 290 2003 1033 1041
18. J.T. Walkup, A.M. Albano, and J. Piacentini Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety N Engl J Med 359 2008 2753 2766
19. D.J. Safer, and J.M. Zito Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents J Child Adolesc Psychopharmacol 16 2006 159 169
20. Hammad TA. Review and Evaluation of Clinical Data: Relationship between psychotropic drugs and pediatric suicidality. US Food and Drug Administration website. 2004. Available at: http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf. Accessed December 8, 2014.
21. J.A. Bridge, S. Iyengar, and C.B. Salary Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials JAMA 297 2007 1683 1696
22. C.U. Correll, J.B. Penzner, and U.H. Parikh Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents Child Adolesc Psychiatr Clin N Am 15 2006 177 206
23. M. Olfson, S.C. Marcus, M.M. Weissman, and P.S. Jensen National trends in the use of psychotropic medications by children J Am Acad Child Adolesc Psychiatry 41 2002 514 521
24. L.L. Greenhill, B. Vitiello, and P. Fisher Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology J Am Acad Child Adolesc Psychiatry 43 2004 1488 1496
25. J.M. Zito, D.J. Safer, S. dosReis, J.F. Gardner, M. Boles, and F. Lynch Trends in the prescribing of psychotropic medications to preschoolers JAMA 283 2000 1025 1030
26. TADS Study Team Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) Randomized controlled trial JAMA 292 2004 807 820
27. S.N. Compton, J.T. Walkup, and A.M. Albano Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods Child Adolesc Psychiatry Ment Health 4 2010 1 15
28. P.C. Kendall, S.N. Compton, and J.T. Walkup Clinical characteristics of anxiety disordered youth J Anxiety Disord 24 2010 360 365
29. W. Guy The ECDEU Assessment Manual for Psychopharmacology-Revised 1976 US Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs Rockville, MD
30. D.A. Geller, K.D. Wagner, and G. Emslie Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial J Am Acad Child Adolesc Psychiatry 43 2004 1387 1396
31. P.M. Wehmeier, A. Schacht, M. Lehmann, R.W. Dittmann, S.G. Silva, and J.S. March Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: findings from a patient, parent and physician perspective using items from the Pediatric Adverse Event Rating Scale (PAERS) Child Adolesc Psychiatry Ment Health 2 2008 11
32. Fisher PW, Lake AM, Hundt SR, et al. Columbia Health and Adverse Reactions to Medication Screen (CHARMS): a computerized measure for identifying possible adverse events. Poster presented at the 57th Annual Meeting of the American Academy of Child and Adolecent Psychiatry, October 26-31, 2010, New York, NY.
33. C.B. Taylor, and V.Y. Chang Issues in the dissemination of cognitive-behavior therapy Nord J Psychiatry 62 2008 37 44
34. POTS Treatment Study Team Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial JAMA 292 2004 1969 1976